Product NDC: | 66993-466 |
Proprietary Name: | Olanzapine |
Non Proprietary Name: | Olanzapine |
Active Ingredient(s): | 5 mg/1 & nbsp; Olanzapine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66993-466 |
Labeler Name: | Prasco Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091415 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120515 |
Package NDC: | 66993-466-30 |
Package Description: | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (66993-466-30) |
NDC Code | 66993-466-30 |
Proprietary Name | Olanzapine |
Package Description | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (66993-466-30) |
Product NDC | 66993-466 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Olanzapine |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20120515 |
Marketing Category Name | ANDA |
Labeler Name | Prasco Laboratories |
Substance Name | OLANZAPINE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC] |